Anette Müllertz

Anette Müllertz

Professor

Member of:


    1. 2008
    2. Published

      Colloid structures in media simulating intestinal fed state conditions with and without lipolysis products

      Fatourus, D., Walrand, I., Bergenstahl, B. & Mullertz, Anette , 2008.

      Research output: Contribution to conferencePosterResearch

    3. Published

      Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories

      Hayeshi, R., Hilgendorf, C., Arthursson, P., Augustijns, P., Larsen, Birger Brodin, Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., Masungi, C., Maubon, N., Mols, R., Mullertz, Anette , Mönkkönen, J., O´Driscoll, C., Oppers-Tiemissen, H. M., Ragnarsson, E. G. E., Rooseboom, M. & Ungell, A., 2008, In: European Journal of Pharmaceutical Sciences. 35, 5, p. 383-396

      Research output: Contribution to journalJournal articlepeer-review

    4. Published

      Dynamisk model for fordøjelse af lipidbaserede lægemidler i tarmen

      Larsen, A., Fatourous, D., Jacobsen, Jette & Mullertz, Anette , 2008, In: Dansk Kemi. 89, 8, p. 30-33

      Research output: Contribution to journalJournal article

    5. Published

      Lipid-based formulations for danazol containing a digestible surfactant, labrafil M2125CS: In vivo bioavailability and dynamic in vitro lipolysis

      Larsen, A., Holm, R., Pedersen, M. L. & Mullertz, Anette , 2008, In: Pharmaceutical Research. 25, 12, p. 2769-2777

      Research output: Contribution to journalJournal articlepeer-review

    6. Published

      Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80

      Lind, M. L., Jacobsen, Jette, Holm, R. & Mullertz, Anette , 2008, In: European Journal of Pharmaceutical Sciences. 35, 3, p. 211-218

      Research output: Contribution to journalJournal articlepeer-review

    7. Published

      Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound

      Lue, B., Nielsen, F. S., Magnussen, T., Schou, H. M., Kristensen, K., Jacobsen, L. O. & Mullertz, Anette , 2008, In: European Journal of Pharmaceutics and Biopharmaceutics. 69, 2, p. 648-657

      Research output: Contribution to journalJournal articlepeer-review

    8. Published

      Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state

      Nielsen, F. S., Petersen, K. & Mullertz, Anette , 2008, In: European Journal of Pharmaceutics and Biopharmaceutics. 69, 2, p. 553-562

      Research output: Contribution to journalJournal articlepeer-review

    9. Published

      Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30

      Thybo, P., Pedersen, B. L., Hovgaard, L., Holm, R. & Mullertz, Anette , 2008, In: Pharmaceutical Development and Technology. 13, 5, p. 375-86 11 p.

      Research output: Contribution to journalJournal articlepeer-review

    10. 2007
    11. Published

      Clinical studies with oral lipid based formulations of poorly soluble compounds

      Fatouros, D., Karpf, D. M., Nielsen, Flemming Steen & Mullertz, Anette , 2007, In: Therapeutics and Clinical Risk Management. 3, 4, p. 591-604 13 p.

      Research output: Contribution to journalJournal articlepeer-review

    12. Published

      Morphological observations on a lipid-based drug delivery system during in vitro digestion

      Fatouros, D. G., Bergenstahl, B. & Mullertz, Anette , 2007, In: European Journal of Pharmaceutical Sciences. 31, 2, p. 85-94

      Research output: Contribution to journalJournal articlepeer-review

    ID: 1302503